The induction of an active tumor microenvironment in premalignant and invasive cancer lesions of DBPDE treated mice resemble that seen in a genetically engineered mouse model of oral cancer, the p120ctn knockout mouse with loss of p120ctn targeted to the oral cavity and esophagus [8]. Here, CTNND1 is linked to cancer.